You are here: Industry Insights > Chief Executive Officer

News List

La Jolla Pharmaceutical Appoints CCO contractpharma
March 12, 2019
Darryl Wellinghoff has had 19 years experience in the pharmaceutical industry including 15 years at The Medicines Company.
TraceLink Launches Smart Inventory Tracker contractpharma
March 08, 2019
The software enables companies with warehousing operations to meet both business and compliance needs, including FMD and DSCSA regulations.
ICT Opens US Office & Announces Executive Appointments contractpharma
March 08, 2019
Office to launch in Rockville, Maryland, with the new hires heading regulatory affairs, business development, and quality assurance.
Glenmark appoints Alessandro Riva as CEO of its New Innovation Company biospectrumasia
March 06, 2019
Glenmark Pharmaceuticals has announced that Alessandro Riva, MD, will join its new innovation company as Chief Executive Officer. Alessandro is currently Executive Vice President, Oncology Therapeutics and Cell Therapy for Gilead Sciences.
Gilead, Agenus Enter Immuno-Oncology Pact contractpharma
December 21, 2018
Gilead Sciences and Agenus Inc. have entered into an immuno-oncology (I-O) partnership for the development and commercialization of up to five novel immuno-oncology therapies.
Recipharm to Potentially End Operations in UK Site contractpharma
December 21, 2018
Recipharm has announced it is considering the discontinuance of operations at its solid dose manufacturing facility in Ashton-under-Lyne, UK.
Pfizer, GSK Form Consumer Healthcare JV contractpharma
December 21, 2018
Pfizer Inc. and GlaxoSmithKline have entered into an agreement to create a global consumer healthcare company with their iconic brands.
Orchard & SIRION Enter License Agreement contractpharma
December 17, 2018
Orchard Therapeutics and SIRION Biotech GmbHhave entered into a license agreement, through which Orchard has licensed SIRION’s LentiBOOST™ technology to enhance manufacturing efficiency for certain of Orchard’s ex vivo
WuXi AppTec Expands San Diego Site contractpharma
December 13, 2018
WuXi AppTec's newly expanded facility will establish a center of excellence in screening, discovery biology, pharmacology, and small molecule process R&D including phase I GMP manufacturing.
InveniAI, Kyowa Hakko Kirin Partner for Drug Discovery contractpharma
December 12, 2018
InveniAI Corporation, a global leader in pioneering the application of artificial intelligence (AI) and machine learning (ML), has entered a collaboration agreement with Kyowa Hakko Kirin to use AI and ML for drug discovery.

Previous page 1 2 3 4 Next page